Biodyne Holding, S.A. 4
4 · Hancock Jaffe Laboratories, Inc. · Filed Oct 1, 2020
Insider Transaction Report
Form 4
Biodyne Holding, S.A.
10% Owner
Transactions
- Sale
Common Stock
2020-06-16$0.43/sh−150,000$64,500→ 3,005,433 total - Sale
Common Stock
2020-06-19$0.46/sh−80,000$36,800→ 2,660,693 total - Sale
Common Stock
2020-07-17$0.38/sh−50,000$19,000→ 2,005,433 total - Sale
Common Stock
2020-08-18$0.34/sh−50,000$17,000→ 1,605,433 total - Sale
Common Stock
2020-08-21$0.38/sh−75,000$28,500→ 1,405,433 total - Sale
Common Stock
2020-07-20$0.43/sh−150,000$64,500→ 1,855,433 total - Sale
Common Stock
2020-07-06$0.39/sh−6,450$2,516→ 2,105,433 total - Sale
Common Stock
2020-07-31$0.34/sh−5,000$1,700→ 1,775,433 total - Sale
Common Stock
2020-06-11$0.39/sh−100,000$39,000→ 3,255,433 total - Sale
Common Stock
2020-06-15$0.42/sh−100,000$42,000→ 3,155,433 total - Sale
Common Stock
2020-07-02$0.40/sh−57,000$22,800→ 2,111,883 total - Sale
Common Stock
2020-07-16$0.38/sh−50,000$19,000→ 2,055,433 total - Sale
Common Stock
2020-07-21$0.45/sh−50,000$22,500→ 1,805,433 total - Sale
Common Stock
2020-07-30$0.32/sh−25,000$8,000→ 1,780,433 total - Sale
Common Stock
2020-08-03$0.32/sh−70,000$22,400→ 1,705,433 total - Sale
Common Stock
2020-08-20$0.27/sh−75,000$20,250→ 1,480,433 total - Sale
Common Stock
2020-06-17$0.48/sh−203,100$97,488→ 2,802,333 total - Sale
Common Stock
2020-06-23$0.43/sh−80,000$34,400→ 2,517,507 total - Sale
Common Stock
2020-06-24$0.42/sh−55,530$23,323→ 2,461,977 total - Sale
Common Stock
2020-06-29$0.39/sh−68,094$26,557→ 2,213,883 total - Sale
Common Stock
2020-06-18$0.45/sh−61,640$27,738→ 2,740,693 total - Sale
Common Stock
2020-06-22$0.46/sh−63,186$29,066→ 2,597,507 total - Sale
Common Stock
2020-06-25$0.40/sh−100,000$40,000→ 2,361,977 total - Sale
Common Stock
2020-06-26$0.38/sh−80,000$30,400→ 2,281,977 total - Sale
Common Stock
2020-07-01$0.38/sh−45,000$17,100→ 2,168,883 total - Sale
Common Stock
2020-08-14$0.31/sh−50,000$15,500→ 1,655,433 total - Sale
Common Stock
2020-08-19$0.30/sh−50,000$15,000→ 1,555,433 total
Footnotes (1)
- [F1]1,950,000 is the total number of shares sold and these shares were sold in multiple transactions at an average price of $0.38. The reporting person undertakes to provide to Hancock Laboratories Jaffe, Inc., any security holder of Hancock Jaffe Laboratories, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate transaction at the price set forth in footnote (1) to this Form 4.